Endogenous Enzymes Enable Antimicrobial Activity
- PMID: 33877811
- PMCID: PMC8212940
- DOI: 10.1021/acschembio.0c00894
Endogenous Enzymes Enable Antimicrobial Activity
Abstract
In light of the continued threat of antimicrobial-resistant bacteria, new strategies to expand the repertoire of antimicrobial compounds are necessary. Prodrugs are an underexploited strategy in this effort. Here, we report on the enhanced antimicrobial activity of a prodrug toward bacteria having an enzyme capable of its activation. A screen led us to the sulfurol ester of the antibiotic trans-3-(4-chlorobenzoyl)acrylic acid. An endogenous esterase makes Mycolycibacterium smegmatis sensitive to this prodrug. Candidate esterases were identified, and their heterologous production made Escherichia coli sensitive to the ester prodrug. Taken together, these data suggest a new approach to the development of antimicrobial compounds that takes advantage of endogenous enzymatic activities to target specific bacteria.
Conflict of interest statement
The authors declare no competing financial interest.
Figures



Similar articles
-
Assessing and utilizing esterase specificity in antimicrobial prodrug development.Methods Enzymol. 2022;664:199-220. doi: 10.1016/bs.mie.2021.11.008. Epub 2021 Dec 23. Methods Enzymol. 2022. PMID: 35331374 Free PMC article.
-
Ester-prodrugs of ethambutol control its antibacterial activity and provide rapid screening for mycobacterial hydrolase activity.Bioorg Med Chem Lett. 2017 Oct 1;27(19):4544-4547. doi: 10.1016/j.bmcl.2017.08.057. Epub 2017 Aug 30. Bioorg Med Chem Lett. 2017. PMID: 28882482 Free PMC article.
-
Diazen-1-ium-1,2-diolated and nitrooxyethyl nitric oxide donor ester prodrugs of anti-inflammatory (E)-2-(aryl)-3-(4-methanesulfonylphenyl)acrylic acids: synthesis, cyclooxygenase inhibition, and nitric oxide release studies.Bioorg Med Chem. 2008 Mar 15;16(6):3302-8. doi: 10.1016/j.bmc.2007.12.006. Epub 2007 Dec 8. Bioorg Med Chem. 2008. PMID: 18096394
-
Microbial esterases and ester prodrugs: An unlikely marriage for combating antibiotic resistance.Drug Dev Res. 2019 Feb;80(1):33-47. doi: 10.1002/ddr.21468. Epub 2018 Oct 10. Drug Dev Res. 2019. PMID: 30302779 Free PMC article. Review.
-
Novel approaches for designing 5'-O-ester prodrugs of 3'-azido-2', 3'-dideoxythymidine (AZT).Curr Med Chem. 2000 Oct;7(10):995-1039. doi: 10.2174/0929867003374372. Curr Med Chem. 2000. PMID: 10911016 Review.
Cited by
-
Mammalian Esterase Activity: Implications for Peptide Prodrugs.Biochemistry. 2024 Oct 15;63(20):2580-2593. doi: 10.1021/acs.biochem.4c00446. Epub 2024 Oct 3. Biochemistry. 2024. PMID: 39359146 Free PMC article.
-
Assessing and utilizing esterase specificity in antimicrobial prodrug development.Methods Enzymol. 2022;664:199-220. doi: 10.1016/bs.mie.2021.11.008. Epub 2021 Dec 23. Methods Enzymol. 2022. PMID: 35331374 Free PMC article.
-
Fast Release of Carboxylic Acid inside Cells.ChemMedChem. 2025 May 5;20(9):e202500056. doi: 10.1002/cmdc.202500056. Epub 2025 Feb 17. ChemMedChem. 2025. PMID: 39960147 Free PMC article.
-
Shifting Mycobacterial Serine Hydrolase Activity Visualized Using Multi-Layer In-Gel Activity Assays.Molecules. 2024 Jul 18;29(14):3386. doi: 10.3390/molecules29143386. Molecules. 2024. PMID: 39064965 Free PMC article.
References
-
- Kolter R; van Wezel GP Goodbye to brute force in antibiotic discovery? Nat. Microbiol 2016, 1, 1–2. - PubMed
-
- Lakemeyer M; Zhao W; Mandl FA; Hammann P; Sieber SA Thinking outside the box—novel antibacterials to tackle the resistance crisis. Angew. Chem., Int. Ed 2018, 57, 14440–14475. - PubMed
-
- Clatworthy AE; Pierson E; Hung DT Targeting virulence: A new paradigm for antimicrobial therapy. Nat. Chem. Biol 2007, 3, 541–548. - PubMed
-
- Brown ED; Wright GD Antibacterial drug discovery in the resistance era. Nature 2016, 529, 336–343. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources